Search Results - Vahid Shaygannejad

Refine Results
  1. 1
    A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis

    A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis by Fereshteh Ashtari, Vahid Shaygannejad, Mojtaba Akbari

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial

    Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial by Vahid Shaygannejad, Mohsen Janghorbani, Fereshteh Ashtari, Hamed Dehghan

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Effects of Rivastigmine on Memory and Cognition in Multiple Sclerosis

    Effects of Rivastigmine on Memory and Cognition in Multiple Sclerosis by Vahid Shaygannejad, Mohsen Janghorbani, Fereshteh Ashtari, Hamid Afshar, Naser Zakizade

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis

    The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis by Omid Mirmosayyeb, Vahid Shaygannejad, Narges Ebrahimi, Hamed Ghoshouni, Mahsa Ghajarzadeh

    Published 2025
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    The prevalence of lower urinary tract symptoms based on individual and clinical parameters in patients with multiple sclerosis

    The prevalence of lower urinary tract symptoms based on individual and clinical parameters in patients with multiple sclerosis by Fatemeh Nazari, Vahid Shaygannejad, Mehrdad Mohammadi Sichani, Marjan Mansourian, Valiollah Hajhashemi

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Sexual dysfunction in women with multiple sclerosis: prevalence and impact on quality of life

    Sexual dysfunction in women with multiple sclerosis: prevalence and impact on quality of life by Fatemeh Nazari, Vahid Shaygannejad, Mehrdad Mohammadi Sichani, Marjan Mansourian, Valiollah Hajhashemi

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review

    Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review by Omid Mirmosayyeb, Elham Moases Ghaffary, Saeed Vaheb, Razieh Pourkazemi, Vahid Shaygannejad

    Published 2023
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study

    Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study by Mahdi Barzegar, Saeed Vaheb, Omid Mirmosayyeb, Alireza Afshari-Safavi, Nasim Nehzat, Vahid Shaygannejad

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    COVID-19 infection in a patient with multiple sclerosis treated with fingolimod

    COVID-19 infection in a patient with multiple sclerosis treated with fingolimod by Mahdi Barzegar, Omid Mirmosayyeb, Nasim Nehzat, Reza Sarrafi, Farzin Khorvash, Amir‐Hadi Maghzi, Vahid Shaygannejad

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Prevalence of dysphagia in patients with multiple sclerosis: A systematic review and meta-analysis

    Prevalence of dysphagia in patients with multiple sclerosis: A systematic review and meta-analysis by Omid Mirmosayyeb, Narges Ebrahimi, Arman Shekarian, Alireza Afshari-Safavi, Vahid Shaygannejad, Mahdi Barzegar, Sara Bagherieh

    Published 2023
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis

    Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis by Omid Mirmosayyeb, Serge Brand, Mahdi Barzegar, Alireza Afshari-Safavi, Nasim Nehzat, Vahid Shaygannejad, Dena Sadeghi Bahmani

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    COVID-19 Among Patients With Multiple Sclerosis

    COVID-19 Among Patients With Multiple Sclerosis by Mahdi Barzegar, Omid Mirmosayyeb, Mahsa Gajarzadeh, Alireza Afshari-Safavi, Nasim Nehzat, Saeed Vaheb, Vahid Shaygannejad, Amir‐Hadi Maghzi

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    In Patients With Multiple Sclerosis, Both Objective and Subjective Sleep, Depression, Fatigue, and Paresthesia Improved After 3 Weeks of Regular Exercise

    In Patients With Multiple Sclerosis, Both Objective and Subjective Sleep, Depression, Fatigue, and Paresthesia Improved After 3 Weeks of Regular Exercise by Dena Sadeghi Bahmani, J.P. Kesselring, Malamati Papadimitriou, Jens Bansi, Uwe Pühse, Markus Gerber, Vahid Shaygannejad, Edith Holsboer‐Trachsler, Serge Brand

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Multiple sclerosis and personality traits: associations with depression and anxiety

    Multiple sclerosis and personality traits: associations with depression and anxiety by Saeed Vaheb, Yousef Mokary, Mohammad Yazdan Panah, Aysa Shaygannejad, Alireza Afshari-Safavi, Majid Ghasemi, Vahid Shaygannejad, Elham Moases Ghaffary, Omid Mirmosayyeb

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Islamic fasting and multiple sclerosis

    Islamic fasting and multiple sclerosis by Soodeh Razeghi Jahromi, Mohammad Ali Sahraian, Fereshteh Ashtari, Hormoz Ayromlou, Massoud Etemadifar, Majid Ghaffarpour, Ehsan Mohammadianinejad, Shahriar Nafissi, Alireza Nickseresht, Vahid Shaygannejad, Mansoureh Togha, Hamid Reza Torabi, Shadi Ziaie

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis

    Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis by Tim Spelman, Gabrielle Simoneau, Robert Hyde, Robert Kuhelj, Raed Alroughani, Serkan Özakbaş, Rana Karabudak, Bassem Yamout, Samia J. Khoury, Murat Terzi, Cavit Boz, Dana Horáková, Eva Havrdová, Bianca Weinstock‐Guttman, Francesco Patti, Ayşe Altıntaş, Saloua Mrabet, Riadh Gouider, Jihad Inshasi, Vahid Shaygannejad, Sara Eichau, W. Luke Ward, Helmut Butzkueven

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Prognostic indicators in pediatric clinically isolated syndrome

    Prognostic indicators in pediatric clinically isolated syndrome by Pietro Iaffaldano, Marta Simone, Giuseppe Lucisano, Angelo Ghezzi, G. Coniglio, Vincenzo Brescia Morra, Giuseppe Salemi, Francesco Patti, Alessandra Lugaresi, Guillermo Izquierdo, Roberto Bergamaschi, José Antonio Cabrera-Gómez, Carlo Pozzilli, Enrico Millefiorini, Raed Alroughani, Cavit Boz, Eugenio Pucci, Giovanni Bosco Zimatore, Patrizia Sola, Giacomo Lus, Davide Maimone, Carlo Avolio, Eleonora Cocco, Seyed Aidin Sajedi, Gianfranco Costantino, Pierre Duquette, Vahid Shaygannejad, Thor Petersen, R. Fernandez Bolanos, Damiano Paolicelli, Carla Tortorella, Tim Spelman, Lucia Margari, Maria Pia Amato, Giancarlo Comi, Helmut Butzkueven, María Trojano

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

    Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS by Karen Ribbons, Patrick McElduff, Cavit Boz, María Trojano, Guillermo Izquierdo, Pierre Duquette, Marc Girard, François Grand’Maison, Raymond Hupperts, Pierre Grammond, Celia Oreja‐Guevara, Thor Petersen, Roberto Bergamaschi, Giorgio Giuliani, Michael Barnett, Vincent Van Pesch, Maria Pia Amato, Gerardo Iuliano, Marcela Fiol, Mark Slee, Freek Verheul, Edgardo Cristiano, Ricardo Fernández‐Bolaños, Maria-Laura Saladino, Maria Edite Rio, José Antonio Cabrera-Gómez, Helmut Butzkueven, Erik van Munster, Leontien Den Braber‐Moerland, Daniele Spitaleri, Alessandra Lugaresi, Vahid Shaygannejad, Orla Gray, Norma Deri, Raed Alroughani, Jeannette Lechner‐Scott

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

    Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis by J William L Brown, Alasdair Coles, Dana Horáková, Eva Havrdová, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, María Trojano, Alessandra Lugaresi, Roberto Bergamaschi, Pierre Grammond, Raed Alroughani, Raymond Hupperts, Pamela McCombe, Vincent Van Pesch, Patrizia Sola, Diana Ferraro, François Grand’Maison, Murat Terzi, Jeannette Lechner‐Scott, S Flechter, Mark Slee, Vahid Shaygannejad, Eugenio Pucci, Franco Granella, Vilija Jokubaitis, Mark Willis, Claire M Rice, Neil Scolding, Alastair Wilkins, Owen Pearson, Tjalf Ziemssen, Michael Hutchinson, Katharine Harding, Joanne L. Jones, Christopher McGuigan, Helmut Butzkueven, Tomáš Kalinčík, Neil P. Robertson

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

    Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis by Tomáš Kalinčík, Eva Havrdová, Dana Horáková, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Marco Onofrj, Alessandra Lugaresi, Serkan Özakbaş, Ludwig Kappos, Jens Kühle, Murat Terzi, Jeannette Lechner‐Scott, Cavit Boz, François Grand’Maison, Julie Prévost, Patrizia Sola, Diana Ferraro, Franco Granella, María Trojano, Roberto Bergamaschi, Eugenio Pucci, Recai Türkoğlu, Pamela McCombe, Vincent Van Pesch, Bart Van Wijmeersch, Claudio Solaro, Cristina Ramo‐Tello, Mark Slee, Raed Alroughani, Bassem Yamout, Vahid Shaygannejad, Daniele Spitaleri, José Luis Sánchez-Menoyo, Radek Ampapa, Suzanne Hodgkinson, Rana Karabudak, Ernest Butler, Steve Vucic, Vilija Jokubaitis, Tim Spelman, Helmut Butzkueven

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: